Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed News and Future Directions
Neuromyelitis Optica, Part 3: Treatment and Prevention
PML Death Associated With Tecfidera; FDA Issues Warning
Corticosteroids Ineffective for Many With Relapsing MS
Physical Activity Associated With Improved Quality of Life in People With MS
Tracking Remyelination: Do You See What I See?
Refined Animal Model Led to Phenytoin Clinical Trial
Genomic Double Play
MS Patient, Ph.D.: Is It Too Early to Get Excited About the BCG Vaccine?
Genome-wide Study Brings MS Landscape Into Sharper Focus
Immunopathogenesis of MS
Where There’s Smoke (and Stress), Is There Fire?
MS Patient, Ph.D.: Calling Dr. Thomas Hale
Will Death in French Drug Trial Lead to Tighter Phase 1 Rules?
Corpus Callosum Cross-Section Correlated With Cognitive Decline
MS Research Roundup: February 12, 2014
Early B Cells Found in Gut, Schooled by Microbes
Autologous Stem Cell Transplant Effective in Inflammatory RRMS; Mechanism Emerging
Pregnancy’s Secret Weapon?
PodBlog: B-Cell Double Header
Interferon β and Glatiramer Acetate Are Clinically Similar, Says Cochrane Meta-Analysis
More Signal Abnormalities Seen in Relatives of MS Patients
Decoding Brain Disease
Is the Month-of-Birth Effect on MS Risk a Statistical Fluke?
New iPad App Tracks MS Patient Course
New NARCOMS Analysis Focuses on Symptom-Specific Impairment
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
